Nora Dominguez

Summary

Affiliation: La Plata
Country: Argentina

Publications

  1. ncbi Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study
    Ruben Terg
    Unidad de Hepatologia, Hospital de Gastroenterologia Bonorino Udaondo, Escuela de Medicina, Universidad del Salvador, Avenida Caseros, 2061 1264, Buenos Aires, Argentina
    J Hepatol 37:717-22. 2002
  2. ncbi Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study
    Ruben Terg
    Unidad de Higado, Hospital de Gastroenterologia Dr Bonorino Udaondo, Sección Hepatología, Avenida Caseros 2061, 1264 Buenos Aires, Argentina
    J Hepatol 48:774-9. 2008
  3. ncbi Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study
    Ruben Terg
    Liver Unit and Inflammatory Bowel Diseases Section, Hospital de Gastroenterología Dr Carlos Bonorino Udaondo, Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 38:26-33. 2008
  4. ncbi Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study
    Ruben Terg
    Hospital de Gastroenterologia Dr Bonorino Udaondo, Universidad del Salvador, Buenos Aires, Argentina
    Liver Int 29:415-9. 2009
  5. ncbi Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
    Gabriela Ruffillo
    Liver Unit, Hospital Nacional Profesor Alejandro Posadas, El Palomar, Buenos Aires, Argentina
    J Hepatol 54:160-3. 2011
  6. ncbi Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study
    Raquel Abecasis
    Liver Unit, Hospital de Gastroenterología B Udaondo, Buenos Aires, Argentina
    Hepatology 37:359-65. 2003

Collaborators

  • Eduardo Fassio
  • Monica Guevara
  • David Kravetz
  • Alberto Muñoz Llarena
  • Ruben Terg
  • Raquel Abecasis
  • Gustavo Romero
  • Alberto Munoz
  • Diana Levi
  • Mariano Cartier
  • Carlos Miguez
  • Gabriela Ruffillo
  • Cristina Longo
  • Romina Lucero
  • Graciela Landeira
  • Emma Coronel
  • Estela Alvarez
  • Gisela Gualano
  • Paola Casciato
  • Adrian Gadano
  • Gonzalo Terg
  • Silvina Goncalvez
  • Juan Mazzuco
  • Anibal Gil
  • Silvia Negreira
  • Sergio Huernos
  • Cristina Landeira
  • Alicia Sambuelli
  • Rogelio Isla
  • Julio Argonz
  • Beatriz Ameigeiras
  • Daniel Garcia
  • Jorge Findor
  • Juan Sordá
  • Alberto E Muñoz

Detail Information

Publications6

  1. ncbi Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study
    Ruben Terg
    Unidad de Hepatologia, Hospital de Gastroenterologia Bonorino Udaondo, Escuela de Medicina, Universidad del Salvador, Avenida Caseros, 2061 1264, Buenos Aires, Argentina
    J Hepatol 37:717-22. 2002
    ..To assess the efficacy and safety of naltrexone for the short and long term treatment of pruritus of cholestasis...
  2. ncbi Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study
    Ruben Terg
    Unidad de Higado, Hospital de Gastroenterologia Dr Bonorino Udaondo, Sección Hepatología, Avenida Caseros 2061, 1264 Buenos Aires, Argentina
    J Hepatol 48:774-9. 2008
    ..Until now, primary prophylaxis has not been recommended in these patients. The aim was to investigate the efficacy of long-term administration of ciprofloxacin to prevent SBP...
  3. ncbi Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study
    Ruben Terg
    Liver Unit and Inflammatory Bowel Diseases Section, Hospital de Gastroenterología Dr Carlos Bonorino Udaondo, Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 38:26-33. 2008
    ..However, taking into account that no data are available in South American population, we analyzed the prevalence of PSC in 1,333 patients with UC and the risk for developing colon cancer...
  4. ncbi Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study
    Ruben Terg
    Hospital de Gastroenterologia Dr Bonorino Udaondo, Universidad del Salvador, Buenos Aires, Argentina
    Liver Int 29:415-9. 2009
    ..Intravenous (IV) albumin administration combined with antibiotic treatment has been shown to significantly decrease these risks. Clinical evidence is lacking on which patients are appropriate candidates for albumin treatment...
  5. ncbi Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
    Gabriela Ruffillo
    Liver Unit, Hospital Nacional Profesor Alejandro Posadas, El Palomar, Buenos Aires, Argentina
    J Hepatol 54:160-3. 2011
    ..Two scoring systems, NAFLD fibrosis score and BARD score, were proposed to separate cases with and without severe fibrosis (SF). Our aim was to compare the utility of both scores in patients with biopsy-proven NAFLD...
  6. ncbi Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study
    Raquel Abecasis
    Liver Unit, Hospital de Gastroenterología B Udaondo, Buenos Aires, Argentina
    Hepatology 37:359-65. 2003
    ..However, when bleeding and ascites were considered together, the combined therapy effectively reduced the incidence of both portal-hypertensive complications...